INS and type 2 diabetes mellitus: However, 47% of those who had delayed insulin treatment reported a diagnosis of type 2 diabetes, and 30% received co-treatment with oral glucose-lowering therapy; this is in marked contrast with the 7% who received oral glucose-lowering therapy in the group who received insulin from diagnosis (p < 0.01).